. "Subjects such as women and AIDS, AIDS prevention, clinical trials, insurance coverage reform, and community activism are documented, in addition to issues pertaining to accelerated approval of experimental drugs, compassionate-use protocols for drugs in development, needle exchange programs, and demonstrations." . . . .